Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

December 01, 1995; Volume 48,Issue 6
  • You have access
    beta-Carboline gamma-aminobutyric acidA receptor inverse agonists modulate gamma-aminobutyric acid via the loreclezole binding site as well as the benzodiazepine site.
    A Stevenson, P B Wingrove, P J Whiting and K A Wafford
    Molecular Pharmacology December 1995, 48 (6) 965-969;
  • You have access
    125I-4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5] triazin-5-yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor.
    T M Palmer, S M Poucher, K A Jacobson and G L Stiles
    Molecular Pharmacology December 1995, 48 (6) 970-974;
  • You have access
    Separate promoters in the human A1 adenosine receptor gene direct the synthesis of distinct messenger RNAs that regulate receptor abundance.
    H Ren and G L Stiles
    Molecular Pharmacology December 1995, 48 (6) 975-980;
  • You have access
    Sustained exposure to 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, alters N-methyl-D-aspartate receptor function and subunit composition.
    L H Fossom, A S Basile and P Skolnick
    Molecular Pharmacology December 1995, 48 (6) 981-987;
  • You have access
    Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation.
    H Y Wang, A S Undie and E Friedman
    Molecular Pharmacology December 1995, 48 (6) 988-994;
  • You have access
    Protein kinase C isoform delta is involved in the stimulation of the Na(+)-H+ exchanger in C6 glioma cells.
    C C Chen and M L Wu
    Molecular Pharmacology December 1995, 48 (6) 995-1003;
  • You have access
    Development and use of a receptor antibody to characterize the interaction between somatostatin receptor subtype 1 and G proteins.
    Y Z Gu, P J Brown, D S Loose-Mitchell, P J Stork and A Schonbrunn
    Molecular Pharmacology December 1995, 48 (6) 1004-1014;
  • You have access
    Suppression of two cloned smooth muscle-derived delayed rectifier potassium channels by cholinergic agonists and phorbol esters.
    F Vogalis, M Ward and B Horowitz
    Molecular Pharmacology December 1995, 48 (6) 1015-1023;
  • You have access
    Multiple phosphorylation sites are required for pathway-selective uncoupling of the 5-hydroxytryptamine1A receptor by protein kinase C.
    P M Lembo and P R Albert
    Molecular Pharmacology December 1995, 48 (6) 1024-1029;
  • You have access
    Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants.
    K J Buck and S G Amara
    Molecular Pharmacology December 1995, 48 (6) 1030-1037;
  • You have access
    G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain.
    M P Abbracchio, R Brambilla, S Ceruti, H O Kim, D K von Lubitz, K A Jacobson and F Cattabeni
    Molecular Pharmacology December 1995, 48 (6) 1038-1045;
  • You have access
    Reduced affinity of iodinated forms of Tyr0 C-type natriuretic peptide for rat natriuretic peptide receptor B.
    G Thibault, K L Grove and C F Deschepper
    Molecular Pharmacology December 1995, 48 (6) 1046-1053;
  • You have access
    Cloning and functional expression of a human 5-hydroxytryptamine type 3AS receptor subunit.
    D Belelli, J M Balcarek, A G Hope, J A Peters, J J Lambert and T P Blackburn
    Molecular Pharmacology December 1995, 48 (6) 1054-1062;
  • You have access
    6-Coumarin diazonium salt: a specific affinity label of the Torpedo acetylcholinesterase peripheral site.
    I Schalk, L Ehret-Sabatier, Y Le Feuvre, S Bon, J Massoulie and M Goeldner
    Molecular Pharmacology December 1995, 48 (6) 1063-1067;
  • You have access
    Growth factor-induced Ca2+ responses are differentially modulated by nitric oxide via activation of a cyclic GMP-dependent pathway.
    E Clementi, C Sciorati and G Nisticò
    Molecular Pharmacology December 1995, 48 (6) 1068-1077;
  • You have access
    Mechanism of cytochrome P450 2D6-catalyzed sparteine metabolism in humans.
    T Ebner, C O Meese and M Eichelbaum
    Molecular Pharmacology December 1995, 48 (6) 1078-1086;
  • You have access
    An acidic amino acid in the N-methyl-D-aspartate receptor that is important for spermine stimulation.
    K Williams, K Kashiwagi, J Fukuchi and K Igarashi
    Molecular Pharmacology December 1995, 48 (6) 1087-1098;
  • You have access
    Platelet-derived growth factor receptor is a novel modulator of type A gamma-aminobutyric acid-gated ion channels.
    C F Valenzuela, A Kazlauskas, S J Brozowski, J L Weiner, K A Demali, B J McDonald, S J Moss, T V Dunwiddie and R A Harris
    Molecular Pharmacology December 1995, 48 (6) 1099-1107;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 48, Issue 6
1 Dec 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Cardiac Safety of Doxorubicin
  • Wnt Signaling and Drug Resistance in Cancer
  • Salicylate Blocks Lipolytic Actions of Tumor Necrosis Factor-α in Primary Rat Adipocytes
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics